Home > Products > All > GANCICLOVIR Injection*
Product Image
Please see full prescribing and safety information, including boxed warning, for GANCICLOVIR single-dose vials.

Available in:

  • 500 mg per 10 mL single-dose vial

Benefits:

  • AP Rated
  • Preservative-free
  • Not made with natural rubber latex

Downloads:

PreventIV

GANCICLOVIR Injection*

Brand Name Equivalent: CYTOVENE IV® (CYTOVENE IV is a registered trademark of Cheplapharm Arzneimittel GmbH.)
Therapeutic Category: Anti-Infective

PreventIV Measures® Features:

  • Easy-to-read drug name and dosage strength to aid in identifying the right product
  • Bar codes included on the vial and carton for ease of scanning
  • Unique label design to help products stand out on the shelf
  • Enhanced packaging and labeling designed to promote safety and help reduce the risk of medication errors
NDC
#25021		 Description Strength Fill
Volume 		Concentration Container
Size 		Closure Unit
of Sale
185-11 Glass Vial 500 mg 10 mL 50 mg per mL 10 mL 20 mm 1
185-10 Glass Vial 500 mg 10 mL 50 mg per mL 10 mL 20 mm 25
WARNING: HEMATOLOGIC TOXICITY, IMPAIRMENT OF FERTILITY, FETAL TOXICITY, MUTAGENESIS AND CARCINOGENESIS See full prescribing information for complete boxed warning.
  • Hematologic Toxicity: Granulocytopenia, anemia, thrombocytopenia, and pancytopenia have been reported in patients treated with Ganciclovir Injection. (5.1)
  • Impairment of Fertility: Based on animal data, Ganciclovir Injection may cause temporary or permanent inhibition of spermatogenesis in males and suppression of fertility in females. (5.3)
  • Fetal Toxicity: Based on animal data, Ganciclovir Injection has the potential to cause birth defects in humans. (5.4)
  • Mutagenesis and Carcinogenesis: Based on animal data Ganciclovir Injection has the potential to cause cancer in humans. (5.5)